Antibody Engineering & Therapeutics US 2026
Antibody Engineering & Therapeutics is a scientific conference on antibody discovery, engineering and therapeutic development, held in San Diego each December. It's attended by antibody scientists from industry and academia and their solution providers.
Sunday to Wednesday · 4 days
Marriott Marquis San Diego Marina
Organizer
Published by the organizer
Every year
How often it's held
Checked October 19, 2026
Attendance
Not published
The organizer doesn't publish attendance or exhibitor numbers.
About Antibody Engineering & Therapeutics US 2026
Antibody Engineering & Therapeutics US is a scientific conference on antibody and protein engineering, run by Informa Connect. It's built for antibody scientists, R&D leaders and the solution providers who sell to them. The 2026 edition runs 13 to 16 December 2026 at the Marriott Marquis San Diego Marina. The organizer's 2026 page cites 900+ international attendees, 165 speakers and 97 sponsors. It's also the annual meeting of The Antibody Society, whose members design the scientific program.
900+
International attendees (organizer's 2026 page, edition not stated)
165
Expert speakers (organizer's 2026 page)
97
Sponsors (organizer's 2026 page)
158
Scientific posters (organizer's 2026 page)
10
Hours of dedicated networking
86
Sponsor entries on the 2026 sponsor page (our count, 2 Nov 2026)
What happens at Antibody Engineering & Therapeutics US
The event runs as one pre-conference day followed by three days of talks, posters and an exhibit hall. Sunday, 13 December, holds a full-day training course, two afternoon workshops and an early career session.
The main conference runs 14 to 16 December. Day one opens with a keynote block, the Jim Huston Science Talent Award and a keynote panel.
Two parallel tracks fill the afternoons. Topics include in vitro and in vivo discovery, difficult targets, cell engagers, multispecifics, ADCs and engineered antibody domains.
Sponsors run scientific briefings at breakfast and lunch, and short technology showcases in the exhibit hall. The organizer lists 158 posters and 10 hours of dedicated networking on its 2026 page.
A digital pass adds livestreams of eight tracks and 12 months of on-demand recordings. The workshops and training course aren't livestreamed.
Related events on this site include World ADC London 2027 and the BIO International Convention 2027. The ASCB cell biology meeting also meets in San Diego in December 2026.
Who attends Antibody Engineering & Therapeutics US
The audience is antibody scientists and researchers from biopharma and academia. The organizer says the event suits scientists, academic experts and industry professionals at all career stages.
- Event Partners2
- Platinum Sponsors1
- Gold Sponsors3
- Silver Sponsors9
- Bronze Sponsors16
- Associate Sponsors55
Our count of the official 2026 sponsor page, 2 November 2026. Cyagen and Cyagen Biosciences appear as two entries.2026 · informaconnect.com ↗
Informa's sponsor page describes the crowd as 900+ antibody executives and scientists. Its 2026 home page cites 900+ international attendees but doesn't say which edition that counts.
Across its US, Europe and Asia events, the organizer claims a global audience of more than 30,000 antibody decision makers. That figure covers the whole series, not this conference alone.
The program draws large pharma and biotech teams. The 2026 speaker list includes scientists from Regeneron, Genentech, Amgen, AstraZeneca, Genmab and Xencor.
Informa doesn't publish a breakdown of attendees by job title, seniority or country.
Companies at Antibody Engineering & Therapeutics US 2026
The confirmed companies are mostly discovery platforms, CROs, CDMOs, lab instrument makers and software vendors. All the names below come from the official 2026 sponsor page or the companies' own pages.
Sponsors (24)GenScript, Twist Bioscience, OmniAb and 21 more
- GenScript · 2026Event partner, stand 303
- Twist Bioscience · 2026Event partner, stand 200
- OmniAb · 2026Platinum sponsor, stands 300 and 410
- Ablexis AlivaMab · 2026Gold sponsor, stand 205
- Alloy Therapeutics · 2026Gold sponsor, stand 220
- Amazon · 2026Gold sponsor, stand 201
- ACROBiosystems · 2026Silver sponsor, stand 304
- Benchling · 2026Silver sponsor, stand 111
- Biointron Biological · 2026Silver sponsor, stand 212
- Invenra · 2026Silver sponsor, stand 108
- Nuclera · 2026Silver sponsor, stand 116
- Primrose Bio · 2026Silver sponsor, stand 305
- Siemens · 2026Silver sponsor, stand 213, Dotmatics briefing
- Specifica, an IQVIA business · 2026Silver sponsor
- Thomson Instrument Company · 2026Silver sponsor, stand 218
- Lonza · 2026Bronze sponsor, stand T10
- WuXi Biologics · 2026Bronze sponsor, stand 209
- Rigaku · 2026Bronze sponsor, stand T7
- Cradle Bio · 2026Bronze sponsor
- FairJourney Biologics · 2026Bronze sponsor
- Carterra · 2026Associate sponsor, stand 616
- Agilent Technologies · 2026Associate sponsor, stand 604
- Schrodinger · 2026Associate sponsor, stand 419
- PAIA Biotech GmbH · 2026Associate sponsor, stand 120
Partners (1)The Antibody Society
Exhibitors (6)evitria, Creative Biolabs, Evotec and 3 more
- evitria · 2026Antibody expression services, own event page
- Creative Biolabs · 2026Announced 2026 attendance on its own events page
- Evotec · 2025Booth T11 in 2025, Just Evotec Biologics
- Primrose Bio · 2025Presented and exhibited at booth 305 in 2025
- Adimab · 2025Featured in the organizer's 2025 event guide
- Telesis Bio · 2025Booth 210 in 2025
Big names include Amazon, Siemens, Lonza, Agilent and WuXi Biologics. Specialist antibody discovery firms such as OmniAb, Alloy Therapeutics and Specifica sit in the top tiers.
Several companies also posted their own plans. Creative Biolabs and evitria both announced 2026 booths, and Primrose Bio said it presented and exhibited in 2025.
Exhibitors at Antibody Engineering & Therapeutics US
Exhibitors take booths in a hall that also holds the posters and the breaks. The organizer cites 97 sponsors and 75+ solution providers on its 2026 page.
Informa doesn't run a separate exhibitor directory. Its 2026 sponsor page lists 86 company entries across six tiers in our count, with stand numbers on each profile.
To exhibit or sponsor, companies contact Informa's sales team, split by company name from A to L and M to Z. The why sponsor page offers booths, private meeting rooms, speaking slots and digital campaigns.
Exhibitors get Lead Insights, which Informa calls a lead ranking, scoring and reporting dashboard. It works like other lead retrieval tools.
Informa doesn't publish booth prices. Its sponsorship brochure sits behind a request form.
Sponsors and partners at Antibody Engineering & Therapeutics US
The 2026 event has a tiered sponsor program. Informa's sponsor page names GenScript and Twist Bioscience as event partners and OmniAb as platinum sponsor.
Gold sponsors are Ablexis AlivaMab, Alloy Therapeutics and Amazon. Nine silver, 16 bronze and dozens of associate sponsors follow.
The Antibody Society is the scientific program partner. California Life Sciences is the supporting association, and media partners include mAbs, BioTechniques and BioXconomy.
Sponsor packages bundle stands with scientific briefings, technology showcases and branded receptions. Teams comparing tools to manage deals like these can start with event sponsorship software.
The event's tech
We couldn't identify a third-party registration platform on the event's website.
Antibody Engineering & Therapeutics US attendee list, exhibitor list and sponsor list
Exhibitor list
Published
Sponsor list
Published
Attendee list
Not published or sold
Informa doesn't sell or publish an attendee list. Registered attendees can see the full attendee list inside the ConnectMe app, which opens four weeks before the event.
ConnectMe lets attendees and exhibitors send meeting requests and messages, a form of matchmaking. The organizer says the app opens on 15 November.
The sponsor list doubles as the exhibitor list. It's on the official 2026 sponsors page, with tier, stand number and briefing title for most companies.
Informa warns that outside vendors selling attendee lists aren't approved by the organizers. It also flags hotel booking scams and points guests to its own housing links.
For other ways to research who's attending, see how to find event attendee lists and event intelligence platforms.
See who's attending Antibody Engineering & Therapeutics US
Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending
Speakers at Antibody Engineering & Therapeutics US 2026
Informa has published its 2026 lineup. The opening keynotes on 14 December come from Facundo Batista, Andreas Hougaard Laustsen-Kiel, Susan Kalled and Krista Kinneer.
- Facundo BatistaAssociate Director and Scientific Director, Ragon Institute of MGH, MIT and HarvardKeynote · Evolving Novel Biologics In Vivo · 2026
- Andreas Hougaard Laustsen-KielProfessor and Group Leader for Antibody Technologies, Technical University of DenmarkKeynote · Snakebite Antivenoms En Route to Recombinant Biologics? · 2026
- Susan KalledScientific Advisory Board Member, Commit BiologicsKeynote · The Evolution of Antibody Therapies in Autoimmunity · 2026
- Krista KinneerDirector, Oncology Translational Medicine, AstraZenecaKeynote · From Insight to Impact: Translational Medicine as a Driver of ADC Clinical Success · 2026
More speakers (53)James A. Ernst, Paul Parren, Xin Zhou and 50 more
- James A. ErnstVice President, Development Sciences; Head of Protein Sciences and Technology, XencorModerator · Co-chairs' welcome and opening remarks · 2026
- Paul ParrenFounder and CSO, Gyes BVModerator · Co-chairs' welcome and opening remarks · 2026
- Xin ZhouAssistant Professor of Biological Chemistry and Molecular Pharmacology, Dana-Farber and Harvard Medical SchoolJim Huston Science Talent Award and Presentation · 2026
- Cholpon TilegenovaSenior Principal Scientist, Biologics Discovery, Johnson & Johnson Innovative MedicineJim Huston Science Talent Award and Presentation · 2026
- Andrew KruseProfessor of Biological Chemistry and Molecular Pharmacology, Harvard UniversityDiscovery of G protein-coupled Receptor Modulator Antibody Fragments · 2026
- Naoka HironiwaChief Scientist, Chugai Pharmaceutical2026
- Brandon DeKoskyAssociate Professor of Chemical Engineering, MIT and The Ragon InstituteModerator · 2026
- Dima KozakovProfessor, Stony Brook UniversityModerator · 2026
- Meredith HazenScientist 4, Department of Antibody Engineering, GenentechFrom COVID to Cancer: LNP-mRNA as an Antigen Format for Antibody Discovery · 2026
- George GeorgiouProfessor, Dula D. Cockrell Centennial Chair in Engineering, The University of Texas at AustinUtilizing Repertoire Mining to Complement In Vivo Antibody Discovery · 2026
- Patrick WilsonProfessor, Weill Cornell MedicineNovel Mechanisms of Antibody-Mediated Control of H3N2 Influenza Virus · 2026
- Li PengChief Scientific Officer, Palleon Pharmaceuticals2026
- Katherine SusaPrincipal Investigator, UCSF2026
- Takashi SatoChief Scientist and Technical Architect, Life Science Product Division, Rigaku CorporationFrom VHH to Intact IgG: Overnight Solution-Based Epitope Mapping · 2026
- Udaya RangaswamySenior Director of Translational Biology, Rondo TherapeuticsCombination of Signal 1 and Signal 2 T Cell Engagers for Treatment of Ovarian Cancer · 2026
- Katherine HarrisChief Development Officer, Rondo TherapeuticsModerator · 2026
- Mitchell HoSenior Investigator, Laboratory of Molecular Biology, National Cancer Institute (NIH)Moderator · 2026
- Kipp WeiskopfHead of Antibody Therapeutics and Biologics, Beth Israel Deaconess Medical CenterHigh-throughput Engineering of Bispecific Antibodies to Stimulate Macrophage-mediated Destruction of B-cell Lymphoma · 2026
- Ryan HenriciSenior Director, Translational Research, BigHat BiosciencesMachine Learning Guided Design of Avidity- and Logic-Gated T Cell Engagers · 2026
- Jean-Philippe JulienSenior Scientist, Molecular Medicine, Hospital for Sick Children Research Institute2026
- Yuejiao XianPrincipal Investigator, Incyte2026
- Aujan MehreganInside Sales Manager, BD and Sales, Nuclera2026
- Prashaant KumarGroup Leader, Gene to Protein, NBE-APSL, Aurigene Pharmaceutical ServicesDiscover, Express, De-Risk: Accelerating Antibodies from Single B Cells to Lead Candidates · 2026
- Jay BhattPrincipal Scientist, Johnson & JohnsonModerator · 2026
- Dhaya SeshasayeeDirector of Antibody Discovery, GenentechModerator · 2026
- John MascolaChief Scientific Officer, ModeX TherapeuticsNovel Multispecific Antibodies for Cancer and Immunological Diseases · 2026
- Eric SmithExecutive Director, Bispecifics, Regeneron PharmaceuticalsModerator · 2026
- Gregory MooreDirector, Protein Engineering, Xencor2026
- Xiuling LiDirector, AstraZenecaCD8-Guided T Cell Engager with Potent Preclinical Efficacy and Superior Therapeutic Index · 2026
- Shiva BhowmikPresident, CSO and Founder, Trio PharmaceuticalsTIE-ADC: A Bispecific ADC Platform Eliminating Cancer Cells and Tumor Immunosuppressor Cells · 2026
- Aran LabrijnDirector, Antibody Research and Technologies, Genmab2026
- Oren BeskeHead of Biologics, Twist Bioscience2026
- Megan RiceAssociate Principal Scientist, AstraZenecaExpanding the Toolbox: Non-natural Amino Acids Enable Development of a CD30 Dual-payload ADC · 2026
- Anna WuChair and Professor, Department of Immunology and Theranostics, City of HopeTurning up the Heat: Radioimmunoconjugates for Targeted Radiation Therapy · 2026
- Grace MortensonAssociate Principal Scientist, Merck Research LabsuPAR Targeting Cytotoxic Antibody Drug Conjugates Selectively Deplete Proinflammatory Myeloid Cells · 2026
- Vaishali KapoorAssistant Professor, Radiation Oncology, Washington University School of MedicineModerator · 2026
- Isabel ElliottPostdoctoral Researcher, University of SouthamptonDisulfide Engineering of Immunostimulatory Antibodies for Augmented Receptor Agonism · 2026
- Dzmitry PadhornyResearch Assistant, The University of Texas at AustinComputational Approaches for Antibody and TCR Modeling Design and Discovery · 2026
- John DesjarlaisChief Scientific Officer, Xencor2026
- Bassil I. DahiyatPresident and CEO, Xencor2026
- Andrew M. BradburyChief Scientific Officer, Specifica2026
- Andre LimnanderSenior Director, Immunology and Inflammation, Regeneron2026
- Arvind SivasubramanianSenior Director, Computational Biology and Platform, Adimab2026
- Marissa MockExecutive Director of Protein Therapeutics, Amgen2026
- Felipe De Sousa E MeloDirector, Research Technology and Emerging Modalities, Amgen2026
- Sigrid CornelisDistinguished Scientist, Sanofi2026
- Karen SilenceHead Preclinical Product Development, Argenx2026
- Vanessa BraunsteinSenior Director, TuneLab AI Drug Discovery Platform, Eli Lilly and Company2026
- Nicole Schirle OakdalePrincipal Scientist, Gilead Sciences2026
- Martin SteegmaierChief Scientific Officer, Molecular Partners2026
- Josh XiaoChief Scientific Officer, Nona Biosciences2026
- Sally WardProfessor and Director, University of Southampton2026
- Simon DavisProfessor of Molecular Immunology, University of Oxford2026
Batista leads science at the Ragon Institute of MGH, MIT and Harvard. Laustsen-Kiel heads antibody technologies at the Technical University of Denmark.
Kalled sits on the scientific advisory board of Commit Biologics. Kinneer directs oncology translational medicine at AstraZeneca and speaks on ADCs.
The 2026 speaker list runs to more than 120 names in our count on 2 November 2026. Industry speakers include Xencor CSO John Desjarlais, Regeneron's Eric Smith and ModeX Therapeutics CSO John Mascola.
Session chairs come from The Antibody Society. Its meeting committee is co-chaired by Jonathan Sockolosky and James Ernst of Xencor.
At the 2025 edition, the organizer's guide highlighted talks from BigHat Biosciences, Nabla Bio and Specifica. Those speakers are listed below as 2025 speakers.
Researchers can still present. Anyone with a main conference pass can add a poster for $199, with abstracts due 13 November 2026.
Who spoke at Antibody Engineering & Therapeutics US 2025 (3)
- Peyton Greenside, CEO, BigHat Biosciences
- Surge Biswas, Co-founder and CEO, Nabla Bio
- Andrew Bradbury, Chief Scientific Officer, Specifica
Dates, venue and getting to Antibody Engineering & Therapeutics US
The 2026 edition runs 13 to 16 December at the Marriott Marquis San Diego Marina, 333 West Harbor Drive. The pre-conference day is 13 December.
Informa says the hotel is about 11 minutes by car from San Diego International Airport. The Route 992 airport bus takes about 25 minutes, including a short walk.
Room bookings go through the organizer's hotel page.
Tickets and registration for Antibody Engineering & Therapeutics US
Registration is paid and open to industry and academic attendees. In-person industry passes start at $3,599 for the main conference only, checked in November 2026.
Adding a half-day workshop raises the industry rate to $4,299. The main conference plus the full-day training course costs $4,599. These rates rise by $200 after 20 November.
Separate rates exist for academic, government and nonprofit attendees, postdocs and early career scientists. Young start-ups can apply for a young company rate if they meet strict criteria.
Antibody Society members get 15% off the 2026 conference. Groups of three or more can request group pricing, and a digital pass covers remote attendance.
History of Antibody Engineering & Therapeutics US
Informa says the conference has run for 34 years. It's the flagship of a series that also includes Antibody Engineering & Therapeutics Europe and Asia.
The 2025 edition ran 14 to 17 December 2025 at the Marriott Marquis San Diego. Evotec gave the same dates for its 2025 booth.
Informa Connect is part of Informa PLC, the London-listed events and academic publishing group.
Resources for exhibitors, sponsors and attendees
These official pages cover registration, the program and exhibiting.
- Registration and pass pricesFor in-person passes and rates.
- Full 2026 agendaDay by day with tracks and session times.
- 2026 speakersWith titles and companies.
- 2026 sponsors and exhibitorsWith tiers and stand numbers.
- Why sponsorFor sponsorship options and Lead Insights.
- Pre-conference workshopsFor the 13 December sessions.
- Present a posterWith abstract and PDF deadlines.
- ConnectMe appFor networking and the attendee list.
- Hotel bookingWith the official housing link.
- Venue and transportationWith airport and transit directions.